Exchange: NASDAQ·Updated 07:30 PM EDT

PACB News

News
all
press releases
Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today
The latest trading day saw Pacific Biosciences of California (PACB) settling at $2.3, representing a -15.44% change from its previous close.
Zacks
Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today
The latest trading day saw Pacific Biosciences of California (PACB) settling at $2.3, representing a -15.44% change from its previous close.
Zacks
More News
PacBio Deepens AI Drug-Discovery Push With TychoBio Deal — PACB Stock Takes A Breather After 103% Rally
PacBio will generate full-length RNA data from more than 10,000 samples, which TychoBio will use to train AI models to design treatments for rare diseases
Stocktwits
Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts
Pacific Biosciences of California (PACB) concluded the recent trading session at $2.54, signifying a +1.2% move from its prior day's close.
Zacks
The Wildest Catalyst Stories Hitting the Tape
Today’s session is packed with stories that can move quickly. Among the names attracting attention are Kraig Biocraft Laboratories (OTCQB:KBLB), Pacific Biosciences of California (NASDAQ:PACB), Tenon Medical (NASDAQ:TNON), Faraday Future Intelligent Electric (NASDAQ:FFAI), Creative Media & Community Trust Corporation (NASDAQ:CMCT), Lion Group Holding Ltd. (NASDAQ:LGHL), ImmunityBio, Inc. (NASDAQ:IBRX), Change Agents Corporation (NASDAQ:CHGA), Inventiva S.A. (NASDAQ:IVA), and Quantum-Si Incorporated (NASDAQ:QSI).
24-7 Market News
Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.62, marking a +2.53% move from the previous day.
Zacks
Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today
In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.38, indicating a +2.99% shift from the previous trading day.
Zacks
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know
Pacific Biosciences of California (PACB) closed at $1.27 in the latest trading session, marking a -1.55% move from the prior day.
Zacks
Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?
Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead?
TXG's 84% rally is backed by consumables growth, Atera demand and higher guidance, but weak instruments and valuation raise the bar.
Zacks
PACB Cuts 2026 Outlook as Clinical Adoption Faces Its Crucial Test
PacBio cut its 2026 revenue outlook as weaker instrument demand and a slower SPRQ-Nx transition raised the stakes for clinical adoption.
Zacks

Advertisement|Remove ads.